Cargando…
Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
Kynurenine‐3‐monooxygenase (KMO) is an enzyme that relies on nicotinamide adenine dinucleotide phosphate (NADP), a key site in the kynurenine pathway (KP), which has great effects on neurological diseases, cancer, and peripheral inflammation. This review mainly pay attention to the research of KMO m...
Autores principales: | Lu, Yifei, Shao, Mingmei, Wu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020307/ https://www.ncbi.nlm.nih.gov/pubmed/32148781 http://dx.doi.org/10.1002/fsn3.1418 |
Ejemplares similares
-
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022) -
Structural basis of kynurenine 3-monooxygenase inhibition
por: Amaral, Marta, et al.
Publicado: (2013) -
Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
por: Parrott, Jennifer M., et al.
Publicado: (2015) -
Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019) -
Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
por: Liu, Chun-Yu, et al.
Publicado: (2021)